Vitronectin Antikörper (VTN) (AA 65-93)

Details for Product anti-VTN Antibody No. ABIN2386286
Target
Bindungsspezifität
AA 65-93, N-Term
15
13
8
7
6
5
5
4
4
3
2
2
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
1
Reaktivität
Human
153
54
35
6
3
2
2
2
2
1
1
1
Wirt
Kaninchen
125
42
5
1
1
Klonalität
Polyklonal
Konjugat
Dieser Vitronectin Antikörper ist unkonjugiert
15
12
9
4
4
3
3
3
3
3
3
3
1
1
1
1
1
1
Applikation
Flow Cytometry (FACS), Immunohistochemistry (IHC), ELISA, Western Blotting (WB)
123
86
62
27
24
14
13
12
11
9
9
8
7
5
5
3
2
2
2
2
1
1
1
1
1
Optionen
Immunogen KLH-conjugated synthetic peptide mapping to a fragment of residues within amino acids 65-93 in the N-terminal region of human VTN (P04004).
Isotyp IgG
Kreuzreaktivität Human
Kreuzreaktivität (Details) Calculated cross reactivity: Hu
Produktmerkmale VTN, NT (VTN, Vitronectin, S-protein, Serum-spreading factor, V75, Vitronectin V65 subunit, Vitronectin V10 subunit, Somatomedin-B)
Reinigung Purified by Protein A affinity chromatography.
Target
Andere Bezeichnung VTN (VTN Antibody Abstract)
UniProt P04004
Pathways Autophagie, Smooth Muscle Cell Migration
Applikations-hinweise Optimal working conditions should be determined by the investigator.
Beschränkungen Nur für Forschungszwecke einsetzbar
Format Liquid
Buffer Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
Konservierungs-mittel Sodium azide
Vorsichtsmaßnahmen This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Lagerung -20 °C
Informationen zur Lagerung -20°C